Razuprotafib
Modify Date: 2024-01-02 22:10:12
Razuprotafib structure
|
Common Name | Razuprotafib | ||
|---|---|---|---|---|
| CAS Number | 1008510-37-9 | Molecular Weight | 586.703 | |
| Density | 1.5±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C26H26N4O6S3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of RazuprotafibRazuprotafib is a potent protein tyrosine phosphatase β (HPTPβ) inhibitor. |
| Name | razuprotafib |
|---|---|
| Synonym | More Synonyms |
| Description | Razuprotafib is a potent protein tyrosine phosphatase β (HPTPβ) inhibitor. |
|---|---|
| Related Catalog | |
| References |
[1]. Kevin Peters, et al. METHODS OF TREATING DIABETIC NEPHROPATHY USING HPTPß INHIBITORS. WO2019165349A1 |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Molecular Formula | C26H26N4O6S3 |
| Molecular Weight | 586.703 |
| Exact Mass | 586.101440 |
| LogP | 4.02 |
| Index of Refraction | 1.667 |
| Carbamic acid, N-[(1S)-2-oxo-1-(phenylmethyl)-2-[[(1S)-2-[4-(sulfoamino)phenyl]-1-[2-(2-thienyl)-4-thiazolyl]ethyl]amino]ethyl]-, methyl ester |
| Nα-(Methoxycarbonyl)-N-{(1S)-2-[4-(sulfoamino)phenyl]-1-[2-(2-thienyl)-1,3-thiazol-4-yl]ethyl}-L-phenylalaninamide |
| razuprotafib |
| 0WAX4UT396 |